Recombinant Human GPD1 (C-6His)

Description

EnkiLife provides the Recombinant Human GPD1 (C-6His) protein,aslo know as Glycerol-3-Phosphate Dehydrogenase [NAD(+)] Cytoplasmic,GPD-C,GPDH-C,GPD1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Glycerol-3-Phosphate Dehydrogenase [NAD(+)], Cytoplasmic is produced by our Mammalian expression system and the target gene encoding Met1-Met349 is expressed with a 6His tag at the C-terminus.Accession:P21695. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:38.6 KDa. Background:Glycerol-3-Phosphate Dehydrogenase [NAD(+, Cytoplasmic (GPDH-C) belongs to the NAD-Dependent Glycerol-3-Phosphate Dehydrogenase family. GPDH-C plays a critical role in carbohydrate and lipid metabolism by catalyzing the reversible conversion of Dihydroxyacetone Phosphate (DHAP) and reducing Nicotine Adenine Dinucleotide (NADH) to Glycerol-3-Phosphate (G3P) and NAD+. GPDH-C is inhibited by zinc ions and sulfate. Mutations in this gene are a cause of transient infantile hypertriglyceridemia. GPDH-C is unlike Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH); they have different substrates.